Our lab has developed TRAIL-conjugated liposomes that have proven to be successful in preventing cancer metastases by targeting and neutralizing tumor cells in the circulation in multiple murine tumor models [3,4,5,6], and in ex vivo experiments using cancer patient blood samples [7,8,9]. Here, TNFSF10 is linked to neoplasm.